Artwork

Innehåll tillhandahållet av Unusual Whales. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Unusual Whales eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

Unusual Whales Pod Ep. 43: GLP-1 Therapies for Obesity and Overall Health, Sponsored by Tema $HRTS ETF

1:22:17
 
Dela
 

Manage episode 441659162 series 3384473
Innehåll tillhandahållet av Unusual Whales. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Unusual Whales eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

Unusual Whales Pod Ep. 43: GLP-1 Therapies for Obesity and Overall Health, Sponsored by Tema $HRTS ETF

This episode of the Unusual Whales Pod was recorded Live on September 24th, 2024. Our host is joined by the CEO and CIO of Tema ETFs Maurits Pot and Yuri Khodjamirian, as well as medical and Biopharma experts to discuss the health landscape in regards to Obesity. A range of topics from GLP-1 treatment efficacy such as Ozempic and Wegovy, to the investor’s point of view and how to navigate the potentially volatile world of biopharma stocks. Via their actively managed GLP-1, Obesity & Cardiometabolic ETF, ticker $HRTS, Tema stays on top of developments in the field, and invests in what they say may be the biggest biopharma potential in the markets, right now.

Panel:

Maurits Pot https://x.com/mauritspot

Yuri Khodjamirian https://x.com/YuriKhodjam

Eric Feigl-Ding https://x.com/DrEricDing

Alexandra Sowa https://x.com/AlexandraSowaMD

BioPharmCatalyst https://twitter.com/BPharmCatalyst

Hosted by:

Nicholas FNS: https://twitter.com/NicholasFNS

Unusual Whales: https://twitter.com/unusual_whales

**

Disclaimer:

Any content referenced in the video or on Unusual Whales are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. You can lose some or all of your investment. See terms for more information.

  continue reading

46 episoder

Artwork
iconDela
 
Manage episode 441659162 series 3384473
Innehåll tillhandahållet av Unusual Whales. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Unusual Whales eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

Unusual Whales Pod Ep. 43: GLP-1 Therapies for Obesity and Overall Health, Sponsored by Tema $HRTS ETF

This episode of the Unusual Whales Pod was recorded Live on September 24th, 2024. Our host is joined by the CEO and CIO of Tema ETFs Maurits Pot and Yuri Khodjamirian, as well as medical and Biopharma experts to discuss the health landscape in regards to Obesity. A range of topics from GLP-1 treatment efficacy such as Ozempic and Wegovy, to the investor’s point of view and how to navigate the potentially volatile world of biopharma stocks. Via their actively managed GLP-1, Obesity & Cardiometabolic ETF, ticker $HRTS, Tema stays on top of developments in the field, and invests in what they say may be the biggest biopharma potential in the markets, right now.

Panel:

Maurits Pot https://x.com/mauritspot

Yuri Khodjamirian https://x.com/YuriKhodjam

Eric Feigl-Ding https://x.com/DrEricDing

Alexandra Sowa https://x.com/AlexandraSowaMD

BioPharmCatalyst https://twitter.com/BPharmCatalyst

Hosted by:

Nicholas FNS: https://twitter.com/NicholasFNS

Unusual Whales: https://twitter.com/unusual_whales

**

Disclaimer:

Any content referenced in the video or on Unusual Whales are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. You can lose some or all of your investment. See terms for more information.

  continue reading

46 episoder

Semua episod

×
 
Loading …

Välkommen till Player FM

Player FM scannar webben för högkvalitativa podcasts för dig att njuta av nu direkt. Den är den bästa podcast-appen och den fungerar med Android, Iphone och webben. Bli medlem för att synka prenumerationer mellan enheter.

 

Snabbguide